Company Profile

Innate Pharma SA (NASDAQ: IPHA)
5:30 PM UTC, 07/03/24
Last: $2.15 Change: +0.09 %Change: +4.37% Volume: 6,933
Detailed Quote
Open: $ 2.18   Volume: 6,933
High: $ 2.18   Yield(%) 0.00
Low: $ 2.15   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 166.75M
EPS ($) n/a   Shares Out: 80.95M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -26.43
% Price Change (last 13 weeks): -18.25
% Price Change (last 26 weeks): -24.26
% Price Change (last 52 weeks): -31.49
% Price Change (year to date): -26.43
Management Effectiveness
Return on Equity (%): -14.22
Return on Assets (%): -3.85
Return on Invested Capital (%): -26.28
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): -14.59
Operating Profit Margin (%): -43.18
Price & Volume
50-day Moving Average: $n/a
200-day Moving Average: $n/a
Avg. Daily Vol. (last 50 days): n/a
Avg. Daily Vol. (last 200 days): n/a
52-wk high: $3.29
52-wk low: $1.81
Bid: $1.90
Ask: $2.18
Company Information
Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Hervé Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié, and François Romagné on September 23, 1999 and is headquartered in Marseille, France.
Innate Pharma SA
117, Avenue de Luminy
Marseille PA 13009

Phone: 33.4.30.30.30.30
Fax: n/a
http://www.innate-pharma.com
Per Share Data
Earnings (1year) ($): -0.10
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 0.71
Cash Flow ($): -0.03
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 4.01
Price/Book (x): 3.95
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 3.73
Current Ratio (x): 3.73
LT Debt/Equity (x): 59.65
Total Debt/Equity (x): 76.86



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.